Previous Issue - Issue 39
Issue 39 | 2020
- Foreword
- Strategy
- Research & Development
- Manufacturing
- Advertorials Go to Digital Magazine
Issue 39
PREVIOUS ISSUE
Research & Development
COVID-19
FROM A CHALLENGE TO AN OPPORTUNITY FOR INDIAN PHARMA TO BECOME SELF-RELIANT
China and India are the leading players in bulk drugs and manufacture more than per cent of global bulk drug China is the largest bulk drug supplier in world and India is second As reported by ministry of commerce India exported drugs formulation and biologicals of billion USD in which increased to billion USD in increase
Advertorials
Meeting the Logistics Needs of Asia Pacific’s Growing Clinical Trials
A growing middle class and aging population has fueled the ascent of the Asia Pacific region in the global healthcare industry Now the pharmaceutical sector is responding by tapping more patients in the region for new drug development trials
TISSUE ENGINEERING
Choosing low-endotoxin gelatins for cell cultures
The process requires three essential components an appropriate threedimensional scaffold to support transplantation and growth of cells cells which can be reparative cells that are able to form a functional matrix and biologically active molecules such as cytokines and growth factors that promote the formation of the desired tissue type
TOC for Cleaning Validation Getting started…
Analytical methods for cleaning validation can be broadly classified into two categories specific and nonspecific methods
FPS SWAB TESTING STATION
Performs the swab for COVID-19
FPS is an Italian company specialised in the design and manufacture of micronisation solutions and containment isolation systems for the production of active pharmaceutical ingredients it is mainly addressed to chemical pharmaceutical and cosmetic companies all over the world
